The Pathophysiology of Irritable Bowel SyndromeCME - Medscape

The Pathophysiology of Irritable Bowel Syndrome CMEFaculty and DisclosuresAs an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of aneducation activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevantfinancial relationships” as financial relationships in any amount, occurring within the past 12 months, including financialrelationships of a spouse or life partner, that could create a conflict of interest.Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Foodand Drug Administration, at first mention and where appropriate in the content.AuthorMichael Camilleri, MDProfessor of Medicine, Pharmacology, and Physiology, Mayo Clinic, Rochester, MinnesotaDisclosure: Michael Camilleri, MD, has disclosed the following relevant financial relationships:Served as a speaker or a member of a speakers bureau for: ShireReceived grants for clinical research from: Salix Pharmaceuticals, Sk Life Science, and Tsumura & Co.Dr Camilleri does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDAfor use in the United States.Dr Camilleri does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by theFDA for use in the United States.EditorsJulia MuinoScientific Director, Medscape, LLCDisclosure: Julia Muino has disclosed no relevant financial relationships.Kristen L. DascoliClinical Editor, Medscape, LLCDisclosure: Kristen L. Dascoli has disclosed no relevant financial relationships.CME ReviewerNafeez Zawahir, MDCME Clinical Director, Medscape, LLCDisclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.Pg.4